These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21804217)

  • 1. Evaluation of the aggregation states of monoclonal antibodies by diverse and complementary methods.
    Yoshino T; Ishikawa T; Ishihara T; Takeuchi Y; Yoshikawa H; Yoshida H; Yoshida H; Wakamatsu K
    Biol Pharm Bull; 2011; 34(8):1273-8. PubMed ID: 21804217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Product and process understanding to relate the effect of freezing method on glycation and aggregation of lyophilized monoclonal antibody formulations.
    Awotwe-Otoo D; Agarabi C; Read EK; Lute S; Brorson KA; Khan MA
    Int J Pharm; 2015 Jul; 490(1-2):341-50. PubMed ID: 25835267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.
    Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Volkin DB; Weis DD
    MAbs; 2015; 7(1):84-95. PubMed ID: 25524268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods.
    Li W; Yang B; Zhou D; Xu J; Li W; Suen WC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of pH on heat-induced aggregation and degradation of therapeutic monoclonal antibodies.
    Ishikawa T; Ito T; Endo R; Nakagawa K; Sawa E; Wakamatsu K
    Biol Pharm Bull; 2010; 33(8):1413-7. PubMed ID: 20686240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DSF method optimization and its application in predicting protein thermal aggregation kinetics.
    Shi S; Semple A; Cheung J; Shameem M
    J Pharm Sci; 2013 Aug; 102(8):2471-83. PubMed ID: 23754479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of biophysical characterization techniques in predicting monoclonal antibody stability.
    Thiagarajan G; Semple A; James JK; Cheung JK; Shameem M
    MAbs; 2016; 8(6):1088-97. PubMed ID: 27210456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the mAb Aggregation Propensity Using Self-Interaction Chromatography as a Screening Tool.
    Hedberg SHM; Lee D; Mishra Y; Haigh JM; Williams DR
    Anal Chem; 2018 Mar; 90(6):3878-3885. PubMed ID: 29446917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid method for simultaneous evaluation of free light chain content and aggregate content in culture media of Chinese hamster ovary cells expressing monoclonal antibodies for cell line screening.
    Ishii Y; Tsukahara M; Wakamatsu K
    J Biosci Bioeng; 2016 Apr; 121(4):464-70. PubMed ID: 26467692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both Reversible Self-Association and Structural Changes Underpin Molecular Viscoelasticity of mAb Solutions.
    Sarangapani PS; Weaver J; Parupudi A; Besong TMD; Adams GG; Harding SE; Manikwar P; Castellanos MM; Bishop SM; Pathak JA
    J Pharm Sci; 2016 Dec; 105(12):3496-3506. PubMed ID: 27793346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the Degradation Behaviors of a Therapeutic Monoclonal Antibody Associated with pH and Buffer Species.
    Zheng S; Qiu D; Adams M; Li J; Mantri RV; Gandhi R
    AAPS PharmSciTech; 2017 Jan; 18(1):42-48. PubMed ID: 26340951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors to Govern Soluble and Insoluble Aggregate-formation in Monoclonal Antibodies.
    Fukuda J; Iwura T; Yanagihara S; Kano K
    Anal Sci; 2015; 31(12):1233-40. PubMed ID: 26656811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of etanercept degradation under oxidative stress and potential protective effects of various amino acids.
    Lim JY; Kim NA; Lim DG; Kim KH; Hada S; Jeong SH
    Int J Pharm; 2015 Aug; 492(1-2):127-36. PubMed ID: 26187168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Comparative Signature Diagrams to Evaluate Similarity of Storage Stability Profiles of Different IgG1 mAbs.
    Kim JH; Joshi SB; Esfandiary R; Iyer V; Bishop SM; Volkin DB; Middaugh CR
    J Pharm Sci; 2016 Mar; 105(3):1028-35. PubMed ID: 26886311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway.
    Barnard JG; Singh S; Randolph TW; Carpenter JF
    J Pharm Sci; 2011 Feb; 100(2):492-503. PubMed ID: 20803602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparations and immunological characterizations of two lysozyme derivatives dinitrophenylated at lysine-33 and lysine-96, respectively.
    Hirayama A; Fujio H; Dohi Y; Takagaki Y; Kondo K; Amano T
    J Biochem; 1981 Mar; 89(3):963-74. PubMed ID: 7287648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Increased Aggregation Propensity of a Light-Exposed IgG1 Monoclonal Antibody Using Hydrogen Exchange Mass Spectrometry, Biophysical Characterization, and Structural Analysis.
    Bommana R; Chai Q; Schöneich C; Weiss WF; Majumdar R
    J Pharm Sci; 2018 Jun; 107(6):1498-1511. PubMed ID: 29408480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing Conformational Diversity of Fc Domains in Aggregation-Prone Monoclonal Antibodies.
    Majumder S; Jones MT; Kimmel M; Alphonse Ignatius A
    Pharm Res; 2018 Sep; 35(11):220. PubMed ID: 30255351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a non-Arrhenius model for therapeutic monoclonal antibody aggregation.
    Kayser V; Chennamsetty N; Voynov V; Helk B; Forrer K; Trout BL
    J Pharm Sci; 2011 Jul; 100(7):2526-42. PubMed ID: 21268027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates.
    Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ
    J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.